0
     

Report Added
Report already added
Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market in India - Industry Outlook and Forecast 2020-2026

Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market in India - Industry Outlook and Forecast 2020-2026

This report contains market size and forecasts of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs in India, including the following market information:_x000D_
India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
Top Five Competitors in India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market 2019 (%)_x000D_
The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
Total Market by Segment:_x000D_
India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions)_x000D_
India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Segment Percentages, By Type, 2019 (%)_x000D_
Agonist_x000D_
Allosteric Modulator_x000D_
Kinase Inhibitor_x000D_
Monoclonal Antibody_x000D_
Others_x000D_
_x000D_
India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market, By Application, 2015-2020, 2021-2026 ($ millions)_x000D_
India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Segment Percentages, By Application, 2019 (%)_x000D_
Hospital_x000D_
Clinic_x000D_
Others_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
Roche_x000D_
Regeneron Pharmaceuticals_x000D_
Bayer_x000D_
Santen Oy_x000D_
Kanghong Pharmaceuticals_x000D_
Novartis_x000D_
Eli Lilly and Company_x000D_
TRACON Pharmaceuticals_x000D_
Pfizer_x000D_
GSK_x000D_
BIOCAD_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Market by Type_x000D_
1.2.2 Market by Application_x000D_
1.3 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Overall Market Size_x000D_
2.1 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size: 2020 VS 2026_x000D_
2.2 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, Prospects & Forecasts: 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies Ranked by Revenue_x000D_
3.3 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 Top 3 and Top 5 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies in India, by Revenue in 2019_x000D_
3.5 India Manufacturers Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Type_x000D_
3.6 Tier 1, Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players in India_x000D_
3.6.1 List of India Tier 1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies_x000D_
3.6.2 List of India Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies_x000D_
_x000D_
4 Market Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Markets, 2020 & 2026_x000D_
4.1.2 Agonist_x000D_
4.1.3 Allosteric Modulator_x000D_
4.1.4 Kinase Inhibitor_x000D_
4.1.5 Monoclonal Antibody_x000D_
4.1.6 Others_x000D_
4.2 By Type - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue & Forecasts_x000D_
4.2.1 By Type - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2015-2020_x000D_
4.2.2 By Type - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2021-2026_x000D_
4.2.3 By Type - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2015-2026_x000D_
5 Market Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2020 & 2026_x000D_
5.1.2 Hospital_x000D_
5.1.3 Clinic_x000D_
5.1.4 Others_x000D_
5.2 By Application - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue & Forecasts_x000D_
5.2.1 By Application - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2015-2020_x000D_
5.2.2 By Application - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2021-2026_x000D_
5.2.3 By Application - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2015-2026_x000D_
6 Players Profiles_x000D_
6.1 Roche_x000D_
6.1.1 Roche Corporate Summary_x000D_
6.1.2 Roche Business Overview_x000D_
6.1.3 Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.1.4 Roche Revenue in India (2015-2020)_x000D_
6.1.5 Roche Key News_x000D_
6.2 Regeneron Pharmaceuticals_x000D_
6.2.1 Regeneron Pharmaceuticals Corporate Summary_x000D_
6.2.2 Regeneron Pharmaceuticals Business Overview_x000D_
6.2.3 Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.2.4 Regeneron Pharmaceuticals Revenue in India (2015-2020)_x000D_
6.2.5 Regeneron Pharmaceuticals Key News_x000D_
6.3 Bayer_x000D_
6.3.1 Bayer Corporate Summary_x000D_
6.3.2 Bayer Business Overview_x000D_
6.3.3 Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.3.4 Bayer Revenue in India (2015-2020)_x000D_
6.3.5 Bayer Key News_x000D_
6.4 Santen Oy_x000D_
6.4.1 Santen Oy Corporate Summary_x000D_
6.4.2 Santen Oy Business Overview_x000D_
6.4.3 Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.4.4 Santen Oy Revenue in India (2015-2020)_x000D_
6.4.5 Santen Oy Key News_x000D_
6.5 Kanghong Pharmaceuticals_x000D_
6.5.1 Kanghong Pharmaceuticals Corporate Summary_x000D_
6.5.2 Kanghong Pharmaceuticals Business Overview_x000D_
6.5.3 Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.5.4 Kanghong Pharmaceuticals Revenue in India (2015-2020)_x000D_
6.5.5 Kanghong Pharmaceuticals Key News_x000D_
6.6 Novartis_x000D_
6.6.1 Novartis Corporate Summary_x000D_
6.6.2 Novartis Business Overview_x000D_
6.6.3 Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.6.4 Novartis Revenue in India (2015-2020)_x000D_
6.6.5 Novartis Key News_x000D_
6.7 Eli Lilly and Company_x000D_
6.6.1 Eli Lilly and Company Corporate Summary_x000D_
6.6.2 Eli Lilly and Company Business Overview_x000D_
6.6.3 Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.4.4 Eli Lilly and Company Revenue in India (2015-2020)_x000D_
6.7.5 Eli Lilly and Company Key News_x000D_
6.8 TRACON Pharmaceuticals_x000D_
6.8.1 TRACON Pharmaceuticals Corporate Summary_x000D_
6.8.2 TRACON Pharmaceuticals Business Overview_x000D_
6.8.3 TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.8.4 TRACON Pharmaceuticals Revenue in India (2015-2020)_x000D_
6.8.5 TRACON Pharmaceuticals Key News_x000D_
6.9 Pfizer_x000D_
6.9.1 Pfizer Corporate Summary_x000D_
6.9.2 Pfizer Business Overview_x000D_
6.9.3 Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.9.4 Pfizer Revenue in India (2015-2020)_x000D_
6.9.5 Pfizer Key News_x000D_
6.10 GSK_x000D_
6.10.1 GSK Corporate Summary_x000D_
6.10.2 GSK Business Overview_x000D_
6.10.3 GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.10.4 GSK Revenue in India (2015-2020)_x000D_
6.10.5 GSK Key News_x000D_
6.11 BIOCAD_x000D_
6.11.1 BIOCAD Corporate Summary_x000D_
6.11.2 BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business Overview_x000D_
6.11.3 BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings_x000D_
6.11.4 BIOCAD Revenue in India (2015-2020)_x000D_
6.11.5 BIOCAD Key News_x000D_
_x000D_
7 Key Market Trends & Influences 2021-2026_x000D_
7.1 PESTLE Analysis for India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market_x000D_
7.2 Market Opportunities & Trends_x000D_
7.3 Market Drivers_x000D_
7.4 Market Restraints_x000D_
_x000D_
8 Conclusion_x000D_
_x000D_
9 Appendix_x000D_
9.1 Note_x000D_
9.2 Examples of Clients_x000D_
9.3 Disclaimer_x000D_List of Tables_x000D_
Table 1. Key Players of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales by Companies, (K Units), 2015-2020_x000D_
Table 6. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Price (2015-2020) (US$/Unit)_x000D_
Table 8. India Manufacturers Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Type_x000D_
Table 9. List of India Tier 1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales in India (K Units), 2015-2020_x000D_
Table 14. By Type - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales in India (K Units), 2021-2026_x000D_
Table 15. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales in India, (K Units), 2015-2020_x000D_
Table 18. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales in India, (K Units), 2021-2026_x000D_
Table 19. Roche Corporate Summary_x000D_
Table 20. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 21. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 22. Regeneron Pharmaceuticals Corporate Summary_x000D_
Table 23. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 24. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 25. Bayer Corporate Summary_x000D_
Table 26. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 27. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 28. Santen Oy Corporate Summary_x000D_
Table 29. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 30. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 31. Kanghong Pharmaceuticals Corporate Summary_x000D_
Table 32. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 33. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 34. Novartis Corporate Summary_x000D_
Table 35. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 36. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 37. Eli Lilly and Company Corporate Summary_x000D_
Table 38. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 39. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 40. TRACON Pharmaceuticals Corporate Summary_x000D_
Table 41. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 42. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 43. Pfizer Corporate Summary_x000D_
Table 44. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 45. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 46. GSK Corporate Summary_x000D_
Table 47. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 48. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 49. BIOCAD Corporate Summary_x000D_
Table 50. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings_x000D_
Table 51. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2015-2020)_x000D_
List of Figures_x000D_
Figure 1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Segment by Type_x000D_
Figure 2. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Segment by Application_x000D_
Figure 3. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size in India, (US$, Mn): 2020 VS 2026_x000D_
Figure 6. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. The Top 3 and 5 Players Market Share by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in 2019_x000D_
Figure 8. By Type - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 9. By Type - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share, 2015-2026_x000D_
Figure 10. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 11. By Application - India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share, 2015-2026_x000D_
Figure 12. PEST Analysis for India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market in 2020_x000D_
Figure 13. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Opportunities & Trends in India_x000D_
Figure 14. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Drivers in India_x000D_

Kindly Fill The Form Below

Report Title: Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market in India - Industry Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW